What's new

EMEA-002535-PIP03-19-M01

EMEA-002535-PIP03-19-M01

Jun 24, 2025 - 15:10
 0
EMEA-002535-PIP03-19-M01
EMEA-002535-PIP03-19-M01
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Palynziq, Pegvaliase,...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Xeljanz, Tofacitinib,...

Related Posts

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

EMEA-003260-PIP03-23

EMEA-003260-PIP03-23

Jun 24, 2025  0

Fourteenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 June 2025, 13:00 (CEST) to 23 June 2025, 18:00 (CEST)

Fourteenth meeting of the industry stakeholder platform...

May 15, 2025  0